Dr. John William Stanifer, MD

Dr. Stanifer practices at Munson Healthcare Kidney and Hypertension Specialists in Traverse City, Michigan.

Dr. Stanifer's NPI, 1427373232, was assigned on April 5, 2010. Dr. Stanifer graduated from University of Tennessee, Hsc, College of Medicine in 2010. Dr. Stanifer holds Michigan license 4301116578.

Dr. Stanifer's primary practice is Munson Healthcare Kidney and Hypertension Specialists, at 3537 W Front St, Traverse City, MI 49684 in Grand Traverse County. The practice phone is (231) 935-0338.

Dr. Stanifer's primary practice is Munson Healthcare Kidney and Hypertension Specialists in Traverse City, Michigan. Dr. Stanifer is also affiliated with Munson Medical Center. The medical group on file is Munson Healthcare Endocrinology & Metabolism. Dmand AI also links Dr. Stanifer to 4 more hospitals, 2 dialysis centers, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Stanifer practices, 8 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Stanifer's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dmand AI has Dr. Stanifer's licenses on file in 2 states: Michigan and North Carolina.

CMS data shows 927 Medicare services from Dr. Stanifer across 16 procedure codes in 2024, for 333 Medicare patients. Medicare paid $149,985 for them.

CMS counts 333 Medicare patients who saw Dr. Stanifer in 2024. The largest group is 65 to 74, with 131 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 16% are also on Medicaid. Their average risk score is 3.43, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Stanifer's median patient age at 75, with 45% women.

In 2024, Dr. Stanifer wrote 1,371 Medicare Part D claims for 272 patients. 80% of them were for generic drugs. CMS names the drug for 1,159 of them, across 29 drugs with 11 or more claims each, at $254,486 in total drug cost. In 2023, CMS named 1,512 claims across 31 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Stanifer for performance year 2024, reported as part of a group. Dr. Stanifer accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Stanifer as offering telehealth.

Dmand AI links 40 papers to Dr. Stanifer, published from 2013 to 2023. 2016 was the busiest year, with 6. The most frequent topics are Renal Insufficiency, Chronic, Tanzania and Hypertension. Dr. Stanifer has published most often in PLoS One. Dr. Stanifer's most frequent co-authors are Nathan M. Thielman, MD, Sophie Wolfe Galson, MD and Catherine Ann Staton, MD.

CMS Open Payments shows 28 general payments to Dr. Stanifer from 6 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 88% of the total. Bayer HealthCare Pharmaceuticals Inc. paid the most, $19,611.

Dr. Stanifer graduated from University of Tennessee, Hsc, College of Medicine in 2010.